ADMA Biologics, Inc. (ADMA) のトレーリングPERは 15.7, 予想PER 11.0. トレーリング益回りは 6.37%, 予想益回り 9.11%. PEG 0.19 (Peter Lynch 割安基準 ≤1.0). グレアム数は $5.28.
このページで証明された基準:
SharesGrow 総合スコア： 85/100 6/7 項目が合格。
| Year | P/E (TTM) | PEG レシオ | P/B レシオ | P/S レシオ | 配当利回り |
|---|---|---|---|---|---|
| 2016 | -3.2 | 0.46 | -13.96 | 5.84 | - |
| 2017 | -1.7 | -0.09 | 1.82 | 3.23 | - |
| 2018 | -1.6 | 0.07 | 5.46 | 6.36 | - |
| 2019 | -4.5 | 0.16 | 8.30 | 7.41 | - |
| 2020 | -2.2 | 0.78 | 1.90 | 3.98 | - |
| 2021 | -2.7 | 0.07 | 1.39 | 2.43 | - |
| 2022 | -11.6 | 0.39 | 5.05 | 4.98 | - |
| 2023 | -35.9 | 0.51 | 7.49 | 3.92 | - |
| 2024 | 20.2 | -0.03 | 11.45 | 9.37 | - |
| 2025 | 29.6 | -1.09 | 9.11 | 8.52 | - |
| Year | EPS（希薄化後） | 売上高 | 純利益 | 純利益率 |
|---|---|---|---|---|
| 2016 | $-1.61 | $10.66M | $-19.52M | -183.1% |
| 2017 | $-1.91 | $22.76M | $-43.76M | -192.3% |
| 2018 | $-1.45 | $16.99M | $-65.74M | -387.1% |
| 2019 | $-1.05 | $29.35M | $-57.05M | -194.4% |
| 2020 | $-1.02 | $42.22M | $-87.61M | -207.5% |
| 2021 | $-0.61 | $80.94M | $-84.45M | -104.3% |
| 2022 | $-0.43 | $154.08M | $-85.18M | -55.3% |
| 2023 | $-0.13 | $258.22M | $-28.24M | -10.9% |
| 2024 | $0.81 | $426.45M | $197.67M | 46.4% |
| 2025 | $0.60 | $510.17M | $146.93M | 28.8% |
| Year | EPS（平均） | EPS レンジ | 売上高（平均） | 売上高レンジ | アナリスト数 |
|---|---|---|---|---|---|
| 2026 | $0.96 | $0.87 – $1.03 | $637.57M | $636.42M – $638.72M | 1 |
| 2027 | $1.28 | $1.27 – $1.28 | $778.45M | $777.05M – $779.85M | 1 |
| 2028 | $1.62 | $1.52 – $1.71 | $944.85M | $944.85M – $944.85M | 2 |
| 2029 | $2.01 | $2.00 – $2.01 | $1.13B | $1.13B – $1.13B | 1 |
| 2030 | $2.30 | $2.29 – $2.30 | $1.26B | $1.26B – $1.26B | 1 |
